B. Mirelis

发表

Molecular characterization of OXA-48 carbapenemase-producing Klebsiella pneumoniae strains after a carbapenem resistance increase in Catalonia

Montse Morta, M. Sierra, C. Alonso-Tarrés, 2019, Enfermedades infecciosas y microbiologia clinica (English ed.).

Molecular characterization of OXA-48 carbapenemase-producing Klebsiella pneumoniae strains after a carbapenem resistance increase in Catalonia.

M. Sierra, C. Alonso-Tarrés, M. Argente, 2019, Enfermedades infecciosas y microbiologia clinica.

[Interpretive reading of enterobacteria antibiograms].

E. Miró, B. Mirelis, F. Navarro, 2010, Enfermedades infecciosas y microbiologia clinica.

Extended-spectrum beta-lactamase-producing Enterobacteriaceae in different environments (humans, food, animal farms and sewage).

A. Blanch, P. Cortés, M. Llagostera, 2006, The Journal of antimicrobial chemotherapy.

Surveillance of extended-spectrum beta-lactamases from clinical samples and faecal carriers in Barcelona, Spain.

P. Coll, E. Miró, B. Mirelis, 2005, The Journal of antimicrobial chemotherapy.

Emergence of clinical Escherichia coli isolates with decreased susceptibility to ceftazidime and synergic effect with co-amoxiclav due to SHV-1 hyperproduction.

M. Sabaté, E. Miró, B. Mirelis, 1998, The Journal of antimicrobial chemotherapy.

Increased Resistance to Quinolones in Campylobacter jejuni: A Genetic Analysis of gyrA Gene Mutations in Quinolone‐Resistant Clinical Isolates

J. Ruiz, J. Vila, F. Marco, 1998, Microbiology and immunology.

Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems.

J. Campos, A. Oliver, Á. Soriano, 2020, Enfermedades Infecciosas y Microbiologia Clinica.

Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems.

J. Campos, A. Oliver, Á. Soriano, 2020, Enfermedades infecciosas y microbiologia clinica.

Characterization of the highly variable region surrounding the bla(CTX-M-9) gene in non-related Escherichia coli from Barcelona.

S. Campoy, P. Coll, E. Miró, 2005, The Journal of antimicrobial chemotherapy.

In vitro activity of clofazimine against rapidly growing nonchromogenic mycobacteria

M. Luquin, P. Coll, G. Prats, 1986, Antimicrobial Agents and Chemotherapy.

Clinical and microbiological features of nocardiosis 1997-2003.

P. Coll, M. Gurguí, J. Muñoz, 2007, Journal of medical microbiology.

Bacteriophages and Diffusion of β-lactamase Genes

J. Jofre, M. Muniesa, G. Prats, 2004, Emerging infectious diseases.

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

A. Oliver, Gemma Navarro, J. Rodríguez-Baño, 2008, Archives of internal medicine.

[Infections caused by Clostridium difficile].

B. Mirelis, F. Navarro, D. Rodríguez-Pardo, 2013, Enfermedades infecciosas y microbiologia clinica.

Dot-immunobinding assay with a monoclonal antibody for detection of group B meningococcal antigen

L. Borche, P. Coll, V. Ausina, 1986, European Journal of Clinical Microbiology.

Etiology of surgical site infections after primary total joint arthroplasties

J. Monllau, P. Coll, M. Gurguí, 2014, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Nosocomial bacteremia in a medical-surgical intensive care unit: Epidemiologic characteristics and factors influencing mortality in 111 episodes

J. Rello, M. Ricart, G. Prats, 1994, Intensive Care Medicine.

Increased resistance of enteropathogens to fluoroquinolones in Barcelona, Spain

E. Miró, B. Mirelis, F. Navarro, 1993, European Journal of Clinical Microbiology and Infectious Diseases.

Community Transmission of Extended-Spectrum β-Lactamase

P. Coll, G. Prats, E. Miró, 2003, Emerging infectious diseases.

Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain.

P. Coll, M. Gurguí, E. Miró, 2006, Journal of medical microbiology.

Lack of usefulness of blood cultures to diagnose ventilator-associated pneumonia.

J. Rello, G. Prats, B. Mirelis, 1991, The European respiratory journal.

Prevalence of Clinical Isolates of Escherichia coli Producing Inhibitor-Resistant β-Lactamases at a University Hospital in Barcelona, Spain, over a 3-Year Period

P. Coll, G. Prats, M. Sabaté, 2002, Antimicrobial Agents and Chemotherapy.

Beta-lactamases involved in resistance to broad-spectrum cephalosporins in Escherichia coli and Klebsiella spp. clinical isolates collected between 1994 and 1996, in Barcelona (Spain).

C. Vergés, M. Sabaté, E. Miró, 2002, The Journal of antimicrobial chemotherapy.

Prospective study of bacteremia during transesophageal echocardiography.

F. Carreras, X. Garcia-Moll, X. Borrás, 1993, American heart journal.

[Systemic lupus erythematosus and anti-native-DNA antibodies measured using Crithidia luciliae].

P. Domingo, B. Mirelis, R. Cabezas, 1985 .

Prevalence of colistin resistance in clinical isolates of Enterobacteriaceae: A four-year cross-sectional study.

P. Coll, B. Mirelis, A. Rivera, 2017, The Journal of infection.

Increase in Quinolone Resistance in aHaemophilus influenzae Strain Isolated from a Patient with Recurrent Respiratory Infections Treated with Ofloxacin

J. Ruiz, J. Vila, G. Prats, 1999, Antimicrobial Agents and Chemotherapy.

VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride‐induced cirrhosis

G. Rossi, P. Sancho-Bru, F. Sancho, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Modulation of Inflammatory Response in a Cirrhotic Rat Model with Induced Bacterial Peritonitis

J. González-Navajas, F. Sancho, R. Francés, 2013, PloS one.

Antibiotic Resistance Trends in Enteropathogenic Bacteria Isolated in 1985–1987 and 1995–1998 in Barcelona

T. Llovet, E. Miró, B. Mirelis, 2000, Antimicrobial Agents and Chemotherapy.

Epidemiology of Clostridium difficile Infection and Risk Factors for Unfavorable Clinical Outcomes: Results of a Hospital-Based Study in Barcelona, Spain

Á. Soriano, J. Vila, B. Almirante, 2013, Journal of Clinical Microbiology.

Evaluation of an enzyme immunoassay for verotoxin detection in Escherichia coli.

B. Mirelis, N. Margall, G. Prats, 1996, Microbiologia.

Efficacy of the FilmArray blood culture identification panel for direct molecular diagnosis of infectious diseases from samples other than blood.

P. Coll, B. Mirelis, F. Navarro, 2015, Journal of medical microbiology.

Effect of Lactobacillus johnsonii La1 and antioxidants on intestinal flora and bacterial translocation in rats with experimental cirrhosis.

C. Peralta, E. Schiffrin, G. Soriano, 2002, Journal of hepatology.

Bacteremia and fungemia of unknown origin among patients receiving intensive care.

J. Rello, M. Ricart, G. Prats, 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antral Follicular Gastritis Is Characteristic of Helicobacter pylori Infection

J. Mones, B. Mirelis, S. Sáinz, 1993 .

Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate.

S. Luque, N. Campillo, J. Horcajada, 2016, International journal of antimicrobial agents.

Impact of adherence to individual quality-of-care indicators on the prognosis of bloodstream infection due to Staphylococcus aureus: a prospective observational multicenter cohort.

Á. Soriano, F. Ruffin, V. Fowler, 2022, Clinical Microbiology and Infection.

Rhodomyrtone decreases Staphylococcus aureus SigB activity during exponentially growing phase and inhibits haemolytic activity within membrane vesicles.

J. Hernández, M. Lagarde, M. Rodríguez-Ortega, 2019, Microbial pathogenesis.

Staphylococcus aureus surface protein G (sasG) allelic variants: correlation between biofilm formation and their prevalence in methicillin-resistant S. aureus (MRSA) clones.

J. Niubó, E. Cercenado, E. Loza, 2022, Research in microbiology.

In Vivo Adaptive Resistance to Colistin in Escherichia coli Isolates.

P. Coll, B. Mirelis, A. Rivera, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Detection of mcr-1 colistin resistance gene in polyclonal Escherichia coli isolates in Barcelona, Spain, 2012 to 2015.

P. Coll, B. Mirelis, A. Rivera, 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

First Isolation of a Carbapenem-Hydrolyzing β-Lactamase in Pseudomonas aeruginosa in Spain

P. Nordmann, L. Poirel, S. Bellais, 2002, Antimicrobial Agents and Chemotherapy.

Prevalence of SXT/R391-like integrative and conjugative elements carrying blaCMY-2 in Proteus mirabilis.

M. Toleman, T. Walsh, E. Miró, 2011, The Journal of antimicrobial chemotherapy.

Characterization of aminoglycoside-modifying enzymes in enterobacteriaceae clinical strains and characterization of the plasmids implicated in their diffusion.

P. Coll, E. Miró, B. Mirelis, 2013, Microbial drug resistance.

Characterisation of fluoroquinolone-resistant clinical isolates of Streptococcus pyogenes in Barcelona, Spain.

P. Coll, E. Miró, B. Mirelis, 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Prulifloxacin: a new antibacterial fluoroquinolone

G. Prats, B. Mirelis, V. Rossi, 2006, Expert review of anti-infective therapy.

[Etiology of enteritis in a university general hospital in Barcelona (1992-1995)].

P. Coll, G. Prats, T. Llovet, 1997, Enfermedades infecciosas y microbiologia clinica.

Novel Complex sul1-Type Integron in Escherichia coli Carrying blaCTX-M-9

S. Campoy, J. Barbé, G. Prats, 2002, Antimicrobial Agents and Chemotherapy.

[Sensitivity of enteropathogenic bacteria to furazolidone].

T. Llovet, B. Mirelis, G. Prats, 1990, Enfermedades infecciosas y microbiologia clinica.

Bloodstream Infection Due to Brachyspira pilosicoli in a Patient with Multiorgan Failure

P. Coll, B. Mirelis, A. Rivera, 2011, Journal of Clinical Microbiology.

CMY-2-producing Salmonella enterica, Klebsiella pneumoniae, Klebsiella oxytoca, Proteus mirabilis and Escherichia coli strains isolated in Spain (October 1999-December 2000).

M. Gomáriz, J. Marimón, E. Pérez-Trallero, 2001, The Journal of antimicrobial chemotherapy.

Prevalence of acquired AmpC beta-lactamases in Enterobacteriaceae lacking inducible chromosomal ampC genes at a Spanish hospital from 1999 to 2007.

P. Coll, E. Miró, B. Mirelis, 2010, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

A simple phenotypic method for differentiation between acquired and chromosomal AmpC beta-lactamases in Escherichia coli.

P. Coll, E. Miró, B. Mirelis, 2006, Enfermedades infecciosas y microbiologia clinica.

[Importance of quality control for the detection of β-lactam antibiotic resistance in Enterobacteriaceae].

B. Mirelis, A. Rivera, F. Navarro, 2014, Enfermedades infecciosas y microbiologia clinica.

Salmonella enterica Serovar Virchow with CTX-M-Like β-Lactamase in Spain

J. Ruiz, E. Miró, B. Mirelis, 2000, Journal of Clinical Microbiology.

Salmonella enterica serovar virchow with CTX-M-like beta-lactamase in Spain.

J. Ruiz, E. Miró, B. Mirelis, 2000, Journal of clinical microbiology.

[Resistance to quinolones and beta-lactams in Salmonella enterica due to mutations in topoisomerase-encoding genes, altered cell permeability and expression of an active efflux system].

L. Martínez-Martínez, P. Coll, E. Miró, 2004, Enfermedades infecciosas y microbiologia clinica.

Outbreak of Pseudomonas fluorescens bloodstream infection in a coronary care unit.

F. March, P. Coll, M. Gurguí, 2012, The Journal of hospital infection.

Detection of three stable genetic clones of CTX-M-15-producing Klebsiella pneumoniae in the Barcelona metropolitan area, Spain.

James R. Johnson, G. Prats, C. Alonso-Tarrés, 2009, The Journal of antimicrobial chemotherapy.

Quinolone Resistance-Determining Regions of gyrA andparC in Pasteurella multocida Strains with Different Levels of Nalidixic Acid Resistance

I. Badiola, J. Barbé, M. Llagostera, 2001, Antimicrobial Agents and Chemotherapy.

In Vitro Activity of the Active Metabolite of Prulifloxacin (AF 3013) Compared with Six Other Fluoroquinolones

E. Miró, B. Mirelis, F. Navarro, 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[Comparison of the automatized BacT/ALERT blood culture incubation and reading system and a conventional system].

J. Rello, B. Mirelis, F. Navarro, 1995, Enfermedades infecciosas y microbiologia clinica.

Survival following Staphylococcus aureus bloodstream infection: A prospective multinational cohort study assessing the impact of place of care.

M. Hellmich, F. Ruffin, V. Fowler, 2018, The Journal of infection.

Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial

C. Tebé, Á. Soriano, J. Miro, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Molecular diagnosis of bloodstream infections with a new dual-priming oligonucleotide-based multiplex PCR assay.

R. Martino, P. Coll, B. Mirelis, 2013, Journal of medical microbiology.

Escherichia coli Serotype O15:K52:H1 as a Uropathogenic Clone

J. R. Johnson, P. Coll, G. Prats, 2000, Journal of Clinical Microbiology.

Dissemination of extended-spectrum beta-lactamase-producing bacteria: the food-borne outbreak lesson.

M. Llagostera, E. Miró, B. Mirelis, 2008, The Journal of antimicrobial chemotherapy.

Characterisation of the CTX-M-15-encoding gene in Klebsiella pneumoniae strains from the Barcelona metropolitan area: plasmid diversity and chromosomal integration.

James R. Johnson, G. Prats, A. Andreu, 2010, International journal of antimicrobial agents.

CTX-M-15-H30Rx-ST131 subclone is one of the main causes of healthcare-associated ESBL-producing Escherichia coli bacteraemia of urinary origin in Spain.

J. Rodríguez-Baño, E. Cercenado, L. Martínez-Martínez, 2016, The Journal of antimicrobial chemotherapy.

Non-Cholera Vibrio Septicemia and Meningoencephalitis

B. Mirelis, G. Prats, R. Pericas, 1975 .

Escherichia coli Producing an ACC-1 Class C β-Lactamase Isolated in Barcelona, Spain

M. Giménez, E. Miró, B. Mirelis, 2005, Antimicrobial Agents and Chemotherapy.

Molecular characterisation of acquired and overproduced chromosomal blaAmpC in Escherichia coli clinical isolates.

E. Calbo, P. Coll, M. Rodríguez-Carballeira, 2016, International journal of antimicrobial agents.

In vivo transmission of a plasmid coharbouring bla and qnrB genes between Escherichia coli and Serratia marcescens.

F. de la Cruz, P. Coll, M. P. Garcillán-Barcia, 2010, FEMS microbiology letters.

Invasive pneumococcal disease in HIV-1 infected patients

G. Prats, P. Domingo, B. Mirelis, 1996, The Lancet.

Campylobacter species: identification and resistance to quinolones.

E. Miró, B. Mirelis, F. Navarro, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Increase in beta-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type beta-lactamases.

P. Coll, E. Miró, B. Mirelis, 2008, The Journal of antimicrobial chemotherapy.

Cephalosporin-resistant Escherichia coli among Summer Camp Attendees with Salmonellosis

James R. Johnson, G. Prats, T. Llovet, 2003, Emerging infectious diseases.

Infections caused by escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients

M. Andreu, R. Solá, G. Prats, 1999, Hepatology.

Moraxella catarrhalis bacteraemia in an immunocompetent adult.

G. Prats, P. Domingo, B. Mirelis, 1995, Scandinavian journal of infectious diseases.

Incidence of enteroinvasive Escherichia coli in Spain. A 14-month prospective study.

M. T. Jiménez de Anta, B. Mirelis, M. Salvadó, 1986, Microbiologica.

Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.

A. Oliver, Gemma Navarro, J. Rodríguez-Baño, 2009, The Journal of antimicrobial chemotherapy.

Effect of long-term acid gastric inhibition on bacterial translocation in cirrhotic rats

J. Mones, J. C. Nieto, C. Juárez, 2015, European journal of gastroenterology & hepatology.

Exogenous thymidine and reversal of the inhibitory effect of sulfamethoxazole-trimethoprim on streptococci

P. Coll, V. Ausina, B. Mirelis, 1984, European Journal of Clinical Microbiology.

Polymicrobial bacteremia in critically ill patients

J. Rello, G. Prats, M. Gurguí, 2005, Intensive Care Medicine.

Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum &bgr;-Lactamase–Producing Enterobacteriaceae: Results From the INCREMENT Cohort

A. Oliver, R. Bonomo, Y. Carmeli, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Evaluation of two commercial kits for detection of Helicobacter pylori specific antibodies in patients undergoing gastroscopy. A seroprevalence study in an asymptomatic population].

J. Mones, F. March, P. Coll, 1992, Enfermedades infecciosas y microbiologia clinica.

Intrinsic resistance versus intrinsic resistome: are we talking about the same concept? Reply to 'Resistance to polymyxins in Gram-negative organisms'.

P. Coll, B. Mirelis, A. Rivera, 2017, International Journal of Antimicrobial Agents.

Acquisition and diffusion of bla CTX-M-9 gene by R478-IncHI2 derivative plasmids.

A. Carattoli, L. Villa, P. Coll, 2007, FEMS microbiology letters.

Fermented milk containing Lactobacillus paracasei subsp. paracasei CNCM I-1518 reduces bacterial translocation in rats treated with carbon tetrachloride

C. Manichanh, A. Santiago, P. Sancho-Bru, 2017, Scientific Reports.

In Vitro Activity of the Active Metabolite of Prulifloxacin (AF 3013) Compared with Six Other Fluoroquinolones

E. Miró, B. Mirelis, F. Navarro, 2002, European Journal of Clinical Microbiology and Infectious Diseases.

Efficacy of orally administered penicillin V for prophylaxis of experimentally induced streptococcal endocarditis

J. Garau, B. Mirelis, M. Galera, 1987, Antimicrobial Agents and Chemotherapy.

Comparison of macrorestriction analysis of genomic DNA by pulsed-field gel electrophoresis and ribotyping with conventional methods for differentiation of Escherichia coli 0124 isolates.

F. March, P. Coll, T. Llovet, 1995, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Chracteristics of the infections caused by Escherichia coli resistant, to norfloxacin in hospitalized cirrhotic patients

M. Andreu, R. Solá, G. Prats, 1995 .

VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride‐induced cirrhosis

G. Rossi, P. Sancho-Bru, F. Sancho, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin.

J. Rodríguez-Baño, E. Cercenado, C. Martín, 2014, The Journal of antimicrobial chemotherapy.

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

A. Oliver, Gemma Navarro, J. Rodríguez-Baño, 2008, Archives of internal medicine.

Gastroenteritis etiology in a university hospital during 1983

P. Coll, G. Prats, M. Portús, 1986, European Journal of Epidemiology.

Extended-spectrum β-lactamase-producing Enterobacteriaceae in different environments (humans, food, animal farms and sewage)

A. Blanch, P. Cortés, M. Llagostera, 2006 .

Escherichia coli bacteraemia. Serotype O15:K52:H1 as a urinary pathogen.

J. Blanco, J. Garau, B. Mirelis, 1996, The Journal of hospital infection.